{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:45:25Z","timestamp":1793828725340,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-023-03163-1","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T21:41:37Z","timestamp":1700170897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments"],"prefix":"10.1007","volume":"408","author":[{"given":"Francesco","family":"Santullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ferracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Abatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Attalla El","family":"Halabieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lodoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"D\u2019Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Di Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pecere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"3163_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"3163_CR2","unstructured":"Canadian Cancer Statistics Advisory Committee (2019) Canadian cancer statistics 2019. Canadian Cancer Society, Toronto, ON. Available at: https:\/\/www.cancer.ca\/Canadian-Cancer-Statistics-2019-EN.\u00a0Accessed 30 Nov 2022"},{"key":"3163_CR3","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1245\/S10434-017-5838-Y\/FIGURES\/2","volume":"24","author":"N Ikoma","year":"2017","unstructured":"Ikoma N, Chen HC, Wang X, Blum M, Estrella JS, Fournier K, Mansfield P, Ajani J, Badgwell BD (2017) Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol 24:2679\u20132687. https:\/\/doi.org\/10.1245\/S10434-017-5838-Y\/FIGURES\/2","journal-title":"Ann Surg Oncol"},{"key":"3163_CR4","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3748\/WJG.V22.I3.1114","volume":"22","author":"RA Seshadri","year":"2016","unstructured":"Seshadri RA, Glehen O (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 22:1114. https:\/\/doi.org\/10.3748\/WJG.V22.I3.1114","journal-title":"World J Gastroenterol"},{"key":"3163_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/02656736.2015.1111432","volume":"32","author":"K Polom","year":"2016","unstructured":"Polom K, Marano L, Roviello G, Petrioli R, Piagnerelli R, De Franco L, Marrelli D, Roviello F (2016) International Journal of Hyperthermia Evolution and emerging future of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: from treating the incurable to preventing recurrence Evolution and emerging future of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: from treating the incurable to preventing recurrence. Int J Hyperth 32:173\u2013179. https:\/\/doi.org\/10.3109\/02656736.2015.1111432","journal-title":"Int J Hyperth"},{"key":"3163_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","volume":"18","author":"B Badgwell","year":"2020","unstructured":"Badgwell B, Ikoma N, Murphy MB, Wang X, Estrella J, Roy-Chowdhuri S, Das P, Minsky BD, Lano E, Song S, Mansfield P, Ajani J, Surg A (2020) A Phase II Trial of Cytoreduction, gastrectomy, and hyperthermic intraperitoneal perfusion with chemotherapy for patients with gastric cancer and carcinomatosis or positive cytology. Oncol 18:258\u2013264. https:\/\/doi.org\/10.1245\/s10434-020-08739-5","journal-title":"Oncol"},{"key":"3163_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/JSO.26718","volume":"125","author":"B Badgwell","year":"2022","unstructured":"Badgwell B (2022) Regional therapy trials in peritoneal metastases: the path to standardization of care for gastric cancer. J Surg Oncol 125:64\u201368. https:\/\/doi.org\/10.1002\/JSO.26718","journal-title":"J Surg Oncol"},{"key":"3163_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/IJC.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, Van Gestel YR, Van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE, De Hingh IH (2014) Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 134:622\u2013628. https:\/\/doi.org\/10.1002\/IJC.28373","journal-title":"Int J Cancer"},{"key":"3163_CR9","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1200\/JCO.2007.13.9378","volume":"26","author":"SE Al-Batran","year":"2008","unstructured":"Al-Batran SE, Hartmann JT, Probst S, Schmalenberg H, Hollerbach S, Hofheinz R, Rethwisch V, Seipelt G, Homann N, Wilhelm G, Schuch G, Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, J\u00e4ger E (2008) Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 26:1435\u20131442. https:\/\/doi.org\/10.1200\/JCO.2007.13.9378","journal-title":"J Clin Oncol"},{"key":"3163_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, R\u00fcschoff J, Kang YK (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687\u2013697. https:\/\/doi.org\/10.1016\/S0140-6736(10)61121-X","journal-title":"Lancet"},{"key":"3163_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, Beane JD, Steinberg SM, Beresnev T, Webb CC, Walker M, Toomey MA, Schrump D, Pandalai P, Stojadinovic A, Avital I (2014) Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol 110:275\u2013284. https:\/\/doi.org\/10.1002\/jso.23633","journal-title":"J Surg Oncol"},{"key":"3163_CR12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10157-0","author":"L Marano","year":"2021","unstructured":"Marano L, Marrelli D, Sammartino P, Biacchi D, Graziosi L, Marino E, Coccolini F, Fugazzola P, Valle M, Federici O, Baratti D, Deraco M, Di Giorgio A, Macr\u0131` A, Pasqual EM, Framarini M, Vaira M, Roviello F, Marano L (2021) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with synchronous peritoneal metastases: multicenter study of \u201cItalian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.\u201d Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-021-10157-0","journal-title":"Ann Surg Oncol"},{"key":"3163_CR13","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"P-E Bonnot","year":"2019","unstructured":"Bonnot P-E, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, Bereder J-M, Abboud K, Fr\u00e9d\u00b4 F, Marchal F, Quenet F, Goere D, Msika S, Arvieux C, Pirro N, Wernert R, Rat P, Gagn\u00ec J, Lefevre JH, Courvoisier T, Kianmanesh R, Vaudoyer D, Rivoire M, Meeus P, Passot G, Glehen O (2019) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol 37:2028\u20132040","journal-title":"J Clin Oncol"},{"key":"3163_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/S10120-019-00978-0\/FIGURES\/4","volume":"23","author":"B Rau","year":"2020","unstructured":"Rau B, Brandl A, Piso P, Pelz J, Busch P, Demtr\u00f6der C, Sch\u00fcle S, Schlitt HJ, Roitman M, Tepel J, Sulkowski U, Uzunoglu F, H\u00fcnerbein M, H\u00f6rbelt R, Str\u00f6hlein M, Beckert S, K\u00f6nigsrainer I, K\u00f6nigsrainer A (2020) Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer 23:11\u201322. https:\/\/doi.org\/10.1007\/S10120-019-00978-0\/FIGURES\/4","journal-title":"Gastric Cancer"},{"key":"3163_CR15","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/S10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, Bereder JM, Lorimier G, Quenet F, Elias D (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370\u20132377. https:\/\/doi.org\/10.1245\/S10434-010-1039-7","journal-title":"Ann Surg Oncol"},{"key":"3163_CR16","doi-asserted-by":"publisher","unstructured":"Yang X-J, Huang C-Q, Suo T, Mei L-J, Yang G-L, Cheng F-L, Zhou Y-F, Xiong B, Yonemura Y, Li Y (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18(6):1575\u20131581. https:\/\/doi.org\/10.1245\/s10434-011-1631-5","DOI":"10.1245\/s10434-011-1631-5"},{"key":"3163_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/J.EJSO.2020.05.021","volume":"47","author":"M Alyami","year":"2021","unstructured":"Alyami M, Bonnot PE, Mercier F, Laplace N, Villeneuve L, Passot G, Bakrin N, Kepenekian V, Glehen O (2021) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol 47:123\u2013127. https:\/\/doi.org\/10.1016\/J.EJSO.2020.05.021","journal-title":"Eur J Surg Oncol"},{"key":"3163_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1245\/S10434-021-10860-Y\/TABLES\/4","volume":"29","author":"R Sindayigaya","year":"2021","unstructured":"Sindayigaya R, Dogan C, Demtr\u00f6der CR, Fischer B, Karam E, Buggisch JR, Tempfer CB, Lecomte T, Ouaissi M, Giger-Pabst U (2021) Clinical outcome for patients managed with low-dose cisplatin and doxorubicin delivered as pressurized intraperitoneal aerosol chemotherapy for unresectable peritoneal metastases of gastric cancer. Ann Surg Oncol 29:112\u2013123. https:\/\/doi.org\/10.1245\/S10434-021-10860-Y\/TABLES\/4","journal-title":"Ann Surg Oncol"},{"key":"3163_CR19","doi-asserted-by":"publisher","unstructured":"Di Giorgio A, Macr\u00ec A, Ferracci F, Robella M, Visaloco M, De Manzoni G, Sammartino P, Sommariva A, Biacchi D, Roviello F, Pastorino R, Pires Marafon D, Rotolo S, Casella F, Vaira M (2023) 10 Years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis. Cancers (Basel) 15(4):1125. https:\/\/doi.org\/10.3390\/CANCERS15041125","DOI":"10.3390\/CANCERS15041125"},{"key":"3163_CR20","doi-asserted-by":"publisher","unstructured":"Case A, Prosser S, Peters CJ, Adams R, Gwynne S (2022) Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: a systematic review by the PIPAC UK collaborative. Crit Rev Oncol Hematol 180:103846. https:\/\/doi.org\/10.1016\/J.CRITREVONC.2022.103846","DOI":"10.1016\/J.CRITREVONC.2022.103846"},{"key":"3163_CR21","doi-asserted-by":"publisher","unstructured":"Di Giorgio A, Santullo F, Attalla El Halabieh M, Lodoli C, Abatini C, Alessandra Calegari M, Martini M, Rotolo S, Pacelli F (2021) Clinical and molecular features in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from colorectal cancer.  Gastrointest Surg 25(10):2649\u20132659. https:\/\/doi.org\/10.1007\/s11605-021-05073-3\/Published","DOI":"10.1007\/s11605-021-05073-3\/Published"},{"key":"3163_CR22","doi-asserted-by":"publisher","unstructured":"Santullo F, Pacelli F, Abatini C, Attalla El Halabieh M, Fortunato G, Lodoli C, Giovinazzo F, Rotolo S, Di Giorgio A (2021) Cytoreduction and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin: a single center experience. Front Surg 8:715119. https:\/\/doi.org\/10.3389\/FSURG.2021.715119","DOI":"10.3389\/FSURG.2021.715119"},{"key":"3163_CR23","doi-asserted-by":"publisher","unstructured":"Santullo F, Abatini C, Attalla El Halabieh M, Ferracci F, Lodoli C, Barberis L, Giovinazzo F, Di Giorgio A, Pacelli F (2022) The road to technical proficiency in cytoreductive surgery for peritoneal carcinomatosis: risk-adjusted cumulative summation analysis. Front Surg 9:877970. https:\/\/doi.org\/10.3389\/FSURG.2022.877970\/FULL","DOI":"10.3389\/FSURG.2022.877970\/FULL"},{"key":"3163_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/J.SURONC.2020.05.006","volume":"34","author":"A Di Giorgio","year":"2020","unstructured":"Di Giorgio A, Schena CA, El Halabieh MA, Abatini C, Vita E, Strippoli A, Inzani F, Rodolfino E, Roman\u00f2 B, Pacelli F, Rotolo S (2020) Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): a bidirectional approach for gastric cancer peritoneal metastasis. Surg Oncol 34:270\u2013275. https:\/\/doi.org\/10.1016\/J.SURONC.2020.05.006","journal-title":"Surg Oncol"},{"issue":"2","key":"3163_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejca.2008.10.030","volume":"45","author":"DJ Sargent","year":"2009","unstructured":"Sargent DJ, Rubinstein L, Schwartz L, Dancey JE, Gatsonis C, Dodd LE, Shankar LK (2009) Validation of novel imaging methodologies for use as cancer clinical trial end-points. Eur J Cancer (Oxford, England\u202f: 1990) 45(2):290\u2013299. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.030","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"key":"3163_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L (2016) RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer (Oxford, England\u202f: 1990) 62:132\u2013137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"key":"3163_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/J.YGYNO.2018.05.001","volume":"150","author":"CB Tempfer","year":"2018","unstructured":"Tempfer CB, Giger-Pabst U, Seebacher V, Petersen M, Dogan A, Rezniczek GA (2018) A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. Gynecol Oncol 150:23\u201330. https:\/\/doi.org\/10.1016\/J.YGYNO.2018.05.001","journal-title":"Gynecol Oncol"},{"key":"3163_CR28","unstructured":"Amin MB, Edge SB, Greene FL, Schilsky RL, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup MJ, Brierley JD, Gaspar LE, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (2017) American Joint Committee on Cancer (AJCC). AJCC cancer staging manual, 8th edn. Springer International Publishing: American Joint Commission on Cancer"},{"key":"3163_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0B013E3181B13CA2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, De Oliveira ML, Vauthey JN, Dindo D, Schulick RD, De Santiba\u00f1es E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187\u2013196. https:\/\/doi.org\/10.1097\/SLA.0B013E3181B13CA2","journal-title":"Ann Surg"},{"key":"3163_CR30","doi-asserted-by":"publisher","unstructured":"Manzanedo I, Pereira F, Caro CR, P\u00e9rez-Viejo E, Serrano \u00c1, Calvo AG, Regueira FM, Casado-Adam \u00c1, Cascales-Campos PA, Arteaga X, Garc\u00eda-Fadrique A, G\u00f3mez Sanz R, Garc\u00eda AL, Zozaya G, Arjona \u00c1, Gil Mart\u00ednez J, Manzanedo I (2019) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol 26(8):2615\u20132621. https:\/\/doi.org\/10.1245\/s10434-019-07450-4","DOI":"10.1245\/s10434-019-07450-4"},{"key":"3163_CR31","doi-asserted-by":"publisher","first-page":"S1040","DOI":"10.1016\/j.annonc.2021.08.1485","volume":"32","author":"B Rau","year":"2021","unstructured":"Rau B, Lang H, K\u00f6nigsrainer A, Gockel I, Seeliger H (2021) 1376O the effect of hyperthermic intraperitoneal chemotherapy(HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC)with synchronous peritoneal metastasis (PM): a randomizedmulticentre phase III trial (GASTRIPEC-I-trial). Ann Oncol 32:S1040","journal-title":"Ann Oncol"},{"key":"3163_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/J.EJSO.2020.10.006","volume":"47","author":"A Brandl","year":"2021","unstructured":"Brandl A, Yonemura Y, Glehen O, Sugarbaker P, Rau B (2021) Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI. Eur J Surg Oncol 47:172\u2013180. https:\/\/doi.org\/10.1016\/J.EJSO.2020.10.006","journal-title":"Eur J Surg Oncol"},{"key":"3163_CR33","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12761-0","author":"BL Green","year":"2023","unstructured":"Green BL, Blumenthaler AN, Gamble LA, Mcdonald JD, Robinson K, Connolly M, Epstein M, Hernandez JM, Blakely AM, Badgwell BD, Davis JL (2023) Cytoreduction and HIPEC for gastric carcinomatosis: multi-institutional analysis of two phase II clinical trials. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-022-12761-0","journal-title":"Ann Surg Oncol"},{"key":"3163_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","volume":"133","author":"S Paget","year":"1889","unstructured":"Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 133:571\u2013573. https:\/\/doi.org\/10.1016\/S0140-6736(00)49915-0","journal-title":"Lancet"},{"key":"3163_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/AGS3.12515","volume":"6","author":"K Yoshida","year":"2021","unstructured":"Yoshida K, Yasufuku I, Terashima M, Young Rha S, Moon Bae J, Li G, Katai H, Watanabe M, Seto Y, Hoon Noh S, Kwang Yang H, Ji J, Baba H, Kitagawa Y, Morita S, Nishiyama M, Kodera Y (2021) International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1). Ann Gastroenterol Surg 6:227\u2013240. https:\/\/doi.org\/10.1002\/AGS3.12515","journal-title":"Ann Gastroenterol Surg"},{"key":"3163_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8\u201310. https:\/\/doi.org\/10.1200\/JCO.1995.13.1.8","journal-title":"J Clin Oncol"},{"key":"3163_CR37","doi-asserted-by":"publisher","unstructured":"Al-Batran SE, Goetze TO, Mueller DW, Vogel A, Winkler M, Lorenzen S, Novotny A, Pauligk C, Homann N, Jungbluth T, Reissfelder C, Caca K, Retter S, Horndasch E, Gumpp J, Bolling C, Fuchs KH, Blau W, Padberg W, Pohl M, Wunsch A, Michl P, Mannes F, Schwarzbach M, Schmalenberg H, Hohaus M, Scholz C, Benckert C, Knorrenschild JR, Kanngie\u00dfer V, Zander T, Alakus H, Hofheinz RD, Roedel C, Shah MA, Sasako M, Lorenz D, Izbicki J, Bechstein WO, Lang H, Moenig SP (2017) The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction \u2013 a phase III trial of the German AIO\/CAO-V\/CAOGI. BMC Cancer 17(1):893. https:\/\/doi.org\/10.1186\/S12885-017-3918-9","DOI":"10.1186\/S12885-017-3918-9"},{"key":"3163_CR38","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/J.EJSO.2018.06.036","volume":"44","author":"C Rihuete Caro","year":"2018","unstructured":"Rihuete Caro C, Manzanedo I, Pereira F, Carrion-Alvarez L, Serrano \u00c1, P\u00e9rez-Viejo E (2018) Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. Eur J Surg Oncol 44:1805\u20131810. https:\/\/doi.org\/10.1016\/J.EJSO.2018.06.036","journal-title":"Eur J Surg Oncol"},{"key":"3163_CR39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/J.EJSO.2015.03.231","volume":"41","author":"F Coccolini","year":"2015","unstructured":"Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, Montori G, Ansaloni L (2015) Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. Eur J Surg Oncol 41:911\u2013919. https:\/\/doi.org\/10.1016\/J.EJSO.2015.03.231","journal-title":"Eur J Surg Oncol"},{"key":"3163_CR40","doi-asserted-by":"publisher","unstructured":"Casella F, Bencivenga M, Rosati R, Fumagalli R, Marrelli D, Pacelli F, Macr\u00ec A, Donini A, Torroni L, Pavarana M, De Manzoni G (2022) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne. Pleura Peritoneum 7(3):135\u2013141. https:\/\/doi.org\/10.1515\/pp-2022-0111","DOI":"10.1515\/pp-2022-0111"},{"key":"3163_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T, Campos Bragagnoli A, Liu T, Schenker M, Yanez P, Tehfe M, Kowalyszyn R, Karamouzis MV, Bruges R, Zander T, Pazo-Cid R, Hitre E, Feeney K, Cleary JM, Poulart V, Cullen D, Lei M, Xiao H, Kondo K, Li M, Ajani JA (2021) First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet 398:27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2","journal-title":"Lancet"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-03163-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:28:55Z","timestamp":1705595335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-03163-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3163"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-03163-1","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}